Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Yin

Showing results (441-450 of 470) with videos related to

Pageof 47
Sort By:
Biorxiv : the Preprint Server for Biology|February 3, 2021
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7Pengfei Wang, Manoj S Nair, Lihong Liu, et al.
Nature Communications|December 19, 2019
Wireless, battery-free, fully implantable multimodal and multisite pacemakers for applications in small animal modelsPhilipp Gutruf, Rose T Yin, K Benjamin Lee, et al.
Research Square|February 3, 2021
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody NeutralizationPengfei Wang, Lihong Liu, Sho Iketani, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2023
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patientsPatrick O Hanafin, Andrea Kwa, Alexandre P Zavascki, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2026
Cardiovascular Disease Risk and Falls in Men and Women Living with and Without HIV in MACS/WIHS Combined Cohort StudyElizabeth Vásquez, Mark H Kuniholm, Allison A Appleton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2022
Menopausal Hormone Therapy and Subclinical Cardiovascular Disease in Women With and Without Human Immunodeficiency VirusBrandilyn A Peters, David B Hanna, Anjali Sharma, et al.
AIDS (London, England)|December 16, 2022
Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIVPamela S Douglas, Sara McCallum, Michael T Lu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2017
HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-DimerBarbara S Taylor, Kaku So-Armah, Janet P Tate, et al.
Clinical Pharmacology and Therapeutics|June 17, 2025
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of NephrotoxicityPatrick O Hanafin, Ramya Mahadevan, Gauri G Rao, et al.
Lancet (London, England)|April 20, 2015
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trialsPaul E Sax, David Wohl, Michael T Yin, et al.
Pageof 47

Showing results (441-450 of 470) with videos related to

Sort By:
Pageof 47
Biorxiv : the Preprint Server for Biology|February 3, 2021
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7Pengfei Wang, Manoj S Nair, Lihong Liu, et al.
Nature Communications|December 19, 2019
Wireless, battery-free, fully implantable multimodal and multisite pacemakers for applications in small animal modelsPhilipp Gutruf, Rose T Yin, K Benjamin Lee, et al.
Research Square|February 3, 2021
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody NeutralizationPengfei Wang, Lihong Liu, Sho Iketani, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2023
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patientsPatrick O Hanafin, Andrea Kwa, Alexandre P Zavascki, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2026
Cardiovascular Disease Risk and Falls in Men and Women Living with and Without HIV in MACS/WIHS Combined Cohort StudyElizabeth Vásquez, Mark H Kuniholm, Allison A Appleton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2022
Menopausal Hormone Therapy and Subclinical Cardiovascular Disease in Women With and Without Human Immunodeficiency VirusBrandilyn A Peters, David B Hanna, Anjali Sharma, et al.
AIDS (London, England)|December 16, 2022
Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIVPamela S Douglas, Sara McCallum, Michael T Lu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2017
HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-DimerBarbara S Taylor, Kaku So-Armah, Janet P Tate, et al.
Clinical Pharmacology and Therapeutics|June 17, 2025
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of NephrotoxicityPatrick O Hanafin, Ramya Mahadevan, Gauri G Rao, et al.
Lancet (London, England)|April 20, 2015
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trialsPaul E Sax, David Wohl, Michael T Yin, et al.
Pageof 47